| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 77.25% | -4.32% | -1.84% | 7/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 78.7% | -2.57% | -1.12% | 6/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 79.59% | -2.12% | -0.29% | 6/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 79.82% | -0.88% | -1.13% | 6/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 80.74% | 2.61% | -0.05% | 6/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 80.78% | 1.3% | -0.66% | 4/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 81.31% | 0.81% | 0.96% | 4/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 80.54% | -0.02% | 2.35% | 6/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 78.68% | -2.16% | -1.32% | 10/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 79.74% | -3.15% | -1.14% | 10/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 80.66% | -3.15% | 0.14% | 10/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 80.55% | -3.87% | 0.16% | 10/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 80.42% | -4.83% | -2.33% | 11/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 82.34% | -3.1% | -1.14% | 9/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 83.28% | -1.96% | -0.61% | 7/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 83.79% | -1.73% | -0.84% | 7/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 84.5% | -0.85% | -0.55% | 6/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 84.97% | -0.31% | 0.02% | 6/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 84.95% | -1.08% | -0.38% | 7/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 85.27% | -0.38% | 0.05% | 6/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 85.23% | -0.59% | -0.01% | 6/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 85.24% | -1.13% | -0.75% | 7/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 85.88% | -0.1% | 0.33% | 5/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 85.6% | -0.06% | -0.16% | 7/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 85.74% | 0.49% | -0.55% | 7/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 86.21% | 1.66% | 0.28% | 6/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 85.97% | 1.38% | 0.37% | 4/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 85.65% | 1.43% | 0.39% | 6/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 85.32% | 0.79% | 0.61% | 4/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 84.81% | 0.79% | 0.01% | 6/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 84.8% | 1.12% | 0.42% | 3/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 84.44% | 0.69% | -0.25% | 3/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 84.65% | 2.34% | 0.61% | 3/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 84.14% | 0.25% | 0.33% | 3/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 83.87% | -0.44% | 0% | 5/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 83.87% | -0.56% | 1.39% | 4/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 82.72% | -1.36% | -1.45% | 3/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 83.93% | -0.73% | -0.35% | 6/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 84.23% | 2% | -0.13% | 1/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 84.34% | -0.53% | 0.58% | 3/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 83.86% | 2% | -0.82% | 1/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |

微信公众号
证券之星APP


